Levothyroxine Dose Adjustment Based on Thyroid Function Tests
Primary Hypothyroidism
For adults with primary hypothyroidism, titrate levothyroxine by 12.5 to 25 mcg increments every 4 to 6 weeks based on serum TSH until the patient is clinically euthyroid and TSH returns to normal (0.5-2.0 mIU/L). 1, 2
Monitoring Intervals and Target TSH
- Check TSH and free T4 levels 4 to 6 weeks after any dose adjustment, as the peak therapeutic effect of levothyroxine may not be attained for 4 to 6 weeks 1
- Once stable, annual monitoring typically suffices in non-pregnant adults 2
- Target TSH should be maintained between 0.5-2.0 mIU/L to avoid both under-treatment and over-replacement 2
- Avoid TSH suppression below 0.2 mIU/L, as values ≤0.1 mIU/L carry risks of atrial fibrillation and bone loss 3
Dose Adjustment Increments
- Standard dose adjustments are 12.5 to 25 mcg increments for most adults 1
- For patients at risk of atrial fibrillation or with underlying cardiac disease, titrate more slowly every 6 to 8 weeks rather than every 4 to 6 weeks 1
- Geriatric patients require lower starting doses and slower titration 1
Special Considerations for Inadequate Response
- If TSH remains elevated despite apparently adequate replacement (>300 mcg/day), investigate poor compliance, malabsorption, drug interactions, or food interference 1
- Dosages greater than 200 mcg/day are seldom required; inadequate response to >300 mcg/day is rare and suggests non-adherence or absorption issues 1
Secondary or Tertiary (Central) Hypothyroidism
For central hypothyroidism, do not use TSH to monitor therapy; instead, titrate levothyroxine based on serum free T4 levels, targeting the upper half of the normal range. 1
Monitoring Strategy
- TSH is unreliable in central hypothyroidism because the pituitary dysfunction prevents appropriate TSH response 1
- Maintain free T4 in the upper half of the normal reference range to ensure adequate tissue thyroid hormone levels 1
- Evaluate other pituitary hormones, especially the hypothalamic-pituitary-adrenal axis, as hypocortisolism must be corrected before initiating thyroid hormone replacement 2
Pregnancy
Pregnant patients with pre-existing hypothyroidism should have TSH measured every 4 weeks until stabilized within trimester-specific reference ranges, then once per trimester. 4
Dose Adjustments in Pregnancy
- Increase levothyroxine by 12.5 to 25 mcg per day when TSH rises above trimester-specific ranges 1
- Pre-pregnancy dosage typically increases by approximately 30-50% during pregnancy 1
- Measure TSH and free T4 as soon as pregnancy is confirmed and maintain TSH within trimester-specific reference ranges 1
- Reduce levothyroxine to pre-pregnancy levels immediately after delivery and monitor TSH 4 to 8 weeks postpartum 1
Critical Importance of Adequate Treatment
- Untreated or undertreated hypothyroidism in pregnancy increases risks of preeclampsia, low birth weight, fetal loss, and adverse neurodevelopmental outcomes in offspring 4
- All pregnant women with subclinical hypothyroidism should be treated regardless of TSH level to prevent pregnancy complications and impaired cognitive development 2
Pediatric Patients
For children, titrate levothyroxine every 2 weeks based on age-specific weight-based dosing until TSH or free T4 normalizes. 1
Age-Specific Dosing
- 0-3 months: 10-15 mcg/kg/day 1
- 3-6 months: 8-10 mcg/kg/day 1
- 6-12 months: 6-8 mcg/kg/day 1
- 1-5 years: 5-6 mcg/kg/day 1
- 6-12 years: 4-5 mcg/kg/day 1
- >12 years (growth/puberty incomplete): 2-3 mcg/kg/day 1
- Growth and puberty complete: 1.6 mcg/kg/day 1
Special Pediatric Considerations
- For infants 0-3 months at risk for cardiac failure, start at lower doses and increase every 4 to 6 weeks 1
- For children at risk for hyperactivity, start at one-fourth the recommended dose and increase weekly by one-fourth increments 1
Elderly Patients
Older adults (≥65 years) require approximately one-third lower weight-based dosing than younger populations: 1.09 mcg/kg actual body weight or 1.35 mcg/kg ideal body weight. 5
Geriatric Dosing Principles
- Start with lower doses (less than 1.6 mcg/kg/day) to avoid cardiac complications 1
- 84% of euthyroid elderly individuals achieve target TSH on doses <1.6 mcg/kg 5
- For obese elderly patients, calculate dosing using ideal body weight rather than actual body weight 5
- Titrate more slowly than in younger adults due to age-related changes in thyroid hormone metabolism 6
Common Pitfalls to Avoid
Timing of Blood Draw
- Ensure blood samples are drawn before the patient takes their daily levothyroxine dose 3, 7
- Taking levothyroxine before blood draw can cause spuriously elevated free T4 with non-suppressed TSH, leading to inappropriate dose adjustments 7
- 72-81% of discordant results (high free T4 with normal TSH) occur in levothyroxine users who took their medication before testing 7
Over-Replacement
- Over-replacement is common in clinical practice and increases risk of atrial fibrillation and osteoporosis 2
- Maintain TSH above 0.2 mIU/L to avoid subclinical hyperthyroidism 3
- Some patients with subnormal TSH may have elevated peripheral tissue markers of thyroid hormone excess despite "acceptable" TSH levels 8